By continuing to use Symptoma®, you confirm you accept the cookies. More on
499301 to 499400 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Transjugular intrahepatic portosystemic shunt: current status.
The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.
Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient.
Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme.
Hepatitis C and renal disease: an update.
Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas.
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia.
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.
Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin.
CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.
Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies.
Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations.
GB virus type C: a beneficial infection?
The complement system in systemic autoimmune disease.
GB virus type C infection modulates T-cell activation independently of HIV-1 viral load.
NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases.
Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia.
GB virus type C interactions with HIV: the role of envelope glycoproteins.
Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences.
Efficacy and safety of rituximab in type II mixed cryoglobulinemia.
Regulation of CC chemokine receptor 5 in hepatitis G virus infection.
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.
An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells.
Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.
Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice.
Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia.
Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees.
GB virus C replicates in primary T and B lymphocytes.
GB virus type C/Hepatitis G virus.
A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission.
A role for hepatitis C virus infection in type II cryoglobulinemia.
Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae.
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Persistent GB virus C infection and survival in HIV-infected men.
Flavivirus susceptibility in Aedes aegypti.
Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl.
Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene.
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.
A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).
Lower Extremity Cellulitis, Weight Gain, pain
Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis.
Multidisciplinary management of Hunter syndrome.
Impact of infectious burden on extent and long-term prognosis of atherosclerosis.
Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report.
The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation.
Estimating foodborne gastroenteritis, Australia.
Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome.
Broad RNA interference-mediated antiviral immunity and virus-specific inducible responses in Drosophila.
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy.
Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery.
Functional analysis of Avr9/Cf-9 rapidly elicited genes identifies a protein kinase, ACIK1, that is essential for full Cf-9-dependent disease resistance in tomato.
A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome).
Family Iridoviridae: poor viral relations no longer.
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.
Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
The role of the cytoskeleton during viral infection.
The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase.
Incidence of the mucopolysaccharidoses in Northern Ireland.
SUMO: of branched proteins and nuclear bodies.
Acyclic nucleoside phosphonates: a key class of antiviral drugs.
Hybrid necrosis: autoimmunity as a potential gene-flow barrier in plant species.
Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
Viruses and microRNAs: RISCy interactions with serious consequences.
Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo.
RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2.
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.
Viral mimicry of cytokines, chemokines and their receptors.
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome).
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.
Hepatitis C virus antibodies among risk groups in Spain.
A review of porcine circovirus 2-associated syndromes and diseases.
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration.
Detection of a novel strain of porcine circovirus in pigs with postweaning multisystemic wasting syndrome.
Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication.
Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2).
Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2.
Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Experimental inoculation of conventional pigs with porcine reproductive and respiratory syndrome virus and porcine circovirus 2.
Meeting report: International Autoimmune Hepatitis Group.
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Reproduction of lesions of postweaning multisystemic wasting syndrome in gnotobiotic piglets.
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.
Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus.
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses.
Genetic characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning multisystemic wasting syndrome in different geographic regions of North America and development of a differential PCR-restriction fragment length polymorphism assa...
Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus.
Chronic hepatitis. An update on terminology and reporting.
Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions.
Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.
Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material.
Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.
Pathological, immunohistochemical, and in-situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs.
Porcine circovirus diseases.
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.